Please login to the form below

Not currently logged in


This page shows the latest electroCore news and features for those working in and with pharma, biotech and healthcare.

Electric dreams in medicine

Electric dreams in medicine

Non-implanted electroceuticals. Another such is ElectroCore Medical, which is rolling out a non-implanted device called GammaCore that stimulates the vagal nerve as a means of treating cluster headache and ... ElectroCore has a somewhat different vision

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Patrick Fabbio named CFO at electroCore Patrick Fabbio named CFO at electroCore

    He joins from NPS Pharmaceuticals where he was VP finance. US-based electroceutical healthcare company electroCore has named Patrick Fabbio as chief financial officer. ... ElectroCore founder and CEO JP Errico commented: "I am delighted that Pat has

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • GCI Health

    European: Acelity,  Gilead, Janssen, Pfizer. UK: Acelity, electroCore, MQ (pro bono), Pfizer.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...